Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01752686. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT04188119. IPD Sharing: NO. Countries: 0. Publications: 0.
TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer
ClinicalTrials.gov study NCT07271992. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03794596. IPD Sharing: NO. Countries: 0. Publications: 0.
Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT07107217. IPD Sharing: NO. Countries: 0. Publications: 0.
Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy
ClinicalTrials.gov study NCT06268327. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
ClinicalTrials.gov study NCT01612910. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05522491. IPD Sharing: NO. Countries: 0. Publications: 0.
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06448169. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT01732276. IPD Sharing: Not stated. Countries: 0. Publications: 0.
AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05244993. IPD Sharing: Not stated. Countries: 0. Publications: 0.
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
ClinicalTrials.gov study NCT03175666. IPD Sharing: NO. Countries: 0. Publications: 0.
Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06590558. IPD Sharing: YES. Countries: 0. Publications: 0.
Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06407310. IPD Sharing: NO. Countries: 0. Publications: 0.
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism
ClinicalTrials.gov study NCT05680662. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients
ClinicalTrials.gov study NCT06795503. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07256964. IPD Sharing: YES. Countries: 0. Publications: 0.
Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02685657. IPD Sharing: NO. Countries: 0. Publications: 0.
Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.
ClinicalTrials.gov study NCT02802423. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes
ClinicalTrials.gov study NCT01910870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.